U.S. Markets open in 39 hrs, 59 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,288.54 | 73.03 | 0.65% |
| NASDAQ | 2,245.38 | -6.08 | -0.27% |
| S&P 500 | 1,262.90 | 1.38 | 0.11% |
| Day Low 10:02 AM EDT | 46.179 | |
|---|---|---|
| Day High 12:31 PM EDT | 46.98 |
|
| Range | 0.80 | |
| Volume | 2.38 M | |
| 30-Day Avg. Vol. | 1.51 M |
|
| Difference | 57.80% | |
| Market Cap. | 123.46 B | |
| Change | 4.19 B | |
| Shares Out. | 2.64 B | |
| Percent Traded | 0.05% | |
| Revenue | 45.6 B | |
| Earnings | 10.46 B | |
| EPS (TTM) | 3.69228 |
| 52-Wk Low 3/14/08 | 40.51 | |
|---|---|---|
| 52-Wk High 1/9/08 | 54.64 |
|
| Range | 14.13 | |
| Prev. Close 7/2/08 | 45.18 | |
| Today's Open | 46.89 | |
| Change | 3.78% | |
| Dividend (TTM) | 2.17312 | |
| Div. Yield (TTM) | 4.65% |
|
| Beta | 0.2717 | |
| P/E Ratio (TTM) | 12.12 | |
| P/E Ratio (Fwd.) | 11.00 |
GlaxoSmithKline (GSK) calms your nerves and helps you breathe easier. One of the top five pharmaceutical firms in the world, GSK's top sellers include central nervous system therapies, respiratory drugs, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.84 12/31/07 | 1.00 12/31/07 |
0.16
Beat
|
| Last Quarter | — 3/31/08 | 1.01 3/31/08 |
—
—
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 11.29 B | 45.61 B |
| Gross Profit | 8.71 B | 35.16 B |
| Operating Income | 3.75 B | 14.97 B |
| Net Income | 2.59 B | 10.47 B |
